Brief: PLx Pharma Inc Reports Third Quarter 2021 Results And Provides Business Update
12/11/2021 12:47
Nov 12 (Reuters) - PLx Pharma Inc PLXP.O :
* . REPORTS THIRD QUARTER 2021 RESULTS AND PROVIDES BUSINESS
UPDATE
* Q3 ADJUSTED NON-GAAP LOSS PER SHARE $0.37
* Q3 LOSS PER SHARE $0.80
* Q3 REVENUE $6.6 MILLION
* Q3 EARNINGS PER SHARE VIEW $-0.46, REVENUE VIEW $4.1
MILLION --
REFINITIV IBES DATA
Source text for Eikon: ID:nGNX74N7J6
Further company coverage: PLXP.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on PLx Pharma Winddown
See all newsAustralia's Pilbara Minerals jumps on Pilgangoora lithium resource upgrade
Brief: Plx Pharma Winddown Terminated Employment Of Natasha Giordano, President And CEO, And Rita O'connor, CFO
Brief: PLx Pharma Inc. Enters Into A Stalking Horse Asset Purchase Agreement To Sell Vazalore And Substantially All Of Its Assets
U.S. STOCKS ON THE MOVE-HeartCore, Freight Technologies, MongoDB
Brief: Plx Pharma Inc. Receives Nasdaq Delisting Notice